These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 12360049)
1. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker. Torlakovic E; Torlakovic G; Nguyen PL; Brunning RD; Delabie J Am J Surg Pathol; 2002 Oct; 26(10):1343-50. PubMed ID: 12360049 [TBL] [Abstract][Full Text] [Related]
2. Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma. Khan MR; Ahmad A; Kayani N; Minhas K Asian Pac J Cancer Prev; 2018 Dec; 19(12):3463-3466. PubMed ID: 30583670 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms. Adams H; Liebisch P; Schmid P; Dirnhofer S; Tzankov A Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):96-101. PubMed ID: 18838917 [TBL] [Abstract][Full Text] [Related]
4. Pax5 immunostaining in paraffin-embedded sections of canine non-Hodgkin lymphoma: a novel canine pan pre-B- and B-cell marker. Willmann M; Müllauer L; Guija de Arespacochaga A; Reifinger M; Mosberger I; Thalhammer JG Vet Immunol Immunopathol; 2009 Apr; 128(4):359-65. PubMed ID: 19100628 [TBL] [Abstract][Full Text] [Related]
5. PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms. Desouki MM; Post GR; Cherry D; Lazarchick J Clin Med Res; 2010 Jul; 8(2):84-8. PubMed ID: 20660931 [TBL] [Abstract][Full Text] [Related]
6. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719 [TBL] [Abstract][Full Text] [Related]
7. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Browne P; Petrosyan K; Hernandez A; Chan JA Am J Clin Pathol; 2003 Nov; 120(5):767-77. PubMed ID: 14608905 [TBL] [Abstract][Full Text] [Related]
8. [Expression of B cell-specific activator protein in lymphomas]. Li D; Li GD; Liu WP; Li FY; Zhang WY; Liao DY Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):345-7. PubMed ID: 16185503 [TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of B-cell-specific activator protein of H/RS cell in classical Hodgkin's Lymphoma]. Zhou X; Zhao T; Qi Z; Liu G; Zhu M Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1532-5. PubMed ID: 12609061 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues. Norton AJ; Isaacson PG J Clin Pathol; 1987 Dec; 40(12):1405-12. PubMed ID: 3323247 [TBL] [Abstract][Full Text] [Related]
12. Pax5 expression in non-Hodgkin's lymphomas and acute leukemias. Zhang X; Lin Z; Kim I J Korean Med Sci; 2003 Dec; 18(6):804-8. PubMed ID: 14676435 [TBL] [Abstract][Full Text] [Related]
13. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Foss HD; Reusch R; Demel G; Lenz G; Anagnostopoulos I; Hummel M; Stein H Blood; 1999 Nov; 94(9):3108-13. PubMed ID: 10556196 [TBL] [Abstract][Full Text] [Related]
14. CD20 negative primary diffuse large B cell lymphoma of breast: Role of Pax-5. Shukla S; Awasthi NP; Singh P; Husain N J Cancer Res Ther; 2015; 11(3):658. PubMed ID: 26458662 [TBL] [Abstract][Full Text] [Related]
15. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues. Cartun RW; Coles FB; Pastuszak WT Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020 [TBL] [Abstract][Full Text] [Related]
16. Essential functions of Pax-5 (BSAP) in pro-B cell development. Nutt SL; Thévenin C; Busslinger M Immunobiology; 1997 Dec; 198(1-3):227-35. PubMed ID: 9442394 [TBL] [Abstract][Full Text] [Related]
17. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Narducci MG; Pescarmona E; Lazzeri C; Signoretti S; Lavinia AM; Remotti D; Scala E; Baroni CD; Stoppacciaro A; Croce CM; Russo G Cancer Res; 2000 Apr; 60(8):2095-100. PubMed ID: 10786666 [TBL] [Abstract][Full Text] [Related]
18. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Tiacci E; Pileri S; Orleth A; Pacini R; Tabarrini A; Frenguelli F; Liso A; Diverio D; Lo-Coco F; Falini B Cancer Res; 2004 Oct; 64(20):7399-404. PubMed ID: 15492262 [TBL] [Abstract][Full Text] [Related]
19. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation. Morrison AM; Nutt SL; Thévenin C; Rolink A; Busslinger M Semin Immunol; 1998 Apr; 10(2):133-42. PubMed ID: 9618759 [TBL] [Abstract][Full Text] [Related]
20. PAX-5 is invariably expressed in B-cell lymphomas without plasma cell differentiation. Dong HY; Browne P; Liu Z; Gangi M Histopathology; 2008 Sep; 53(3):278-87. PubMed ID: 18643853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]